Treatment of Bilharzia (Schistosomiasis)
Recommended Treatment Regimens
- The World Health Organization recommends Praziquantel as the drug of choice for treating all forms of schistosomiasis, with specific dosing regimens based on the infecting Schistosoma species 1, 2
- For Schistosoma mansoni, S. intercalatum, and S. guineensis infections, the Centers for Disease Control and Prevention suggests Praziquantel 40 mg/kg orally as a single dose 1
- For Schistosoma japonicum and S. mekongi infections, the World Health Organization recommends Praziquantel 60 mg/kg orally in two divided doses 1
- For infections diagnosed by serology alone from the Asia-Pacific region, the Centers for Disease Control and Prevention recommends Praziquantel 60 mg/kg orally in two divided doses 1
Special Clinical Scenarios
Acute Schistosomiasis (Katayama Syndrome)
- The American Society of Tropical Medicine and Hygiene states that acute schistosomiasis presents in travelers 2-8 weeks after exposure to contaminated water 1
- The Infectious Diseases Society of America recommends corticosteroids, such as prednisolone 30 mg daily for 5 days, to reduce symptom duration in acute schistosomiasis 3
- The World Health Organization advises caution when using dexamethasone, as it may reduce praziquantel levels due to increased metabolism 3
- The Centers for Disease Control and Prevention suggests that Praziquantel should be administered after the acute inflammatory phase in acute schistosomiasis 4, 2
Neuroschistosomiasis
- The World Health Organization recommends Praziquantel 40 mg/kg twice daily for 5 days for CNS involvement in neuroschistosomiasis 5
- The Infectious Diseases Society of America suggests combining Praziquantel with dexamethasone 4 mg four times daily, reducing after 7 days, for a total of 2-6 weeks in neuroschistosomiasis 5
- The American Society of Tropical Medicine and Hygiene advises that in acute neuroschistosomiasis, corticosteroids should be given first, before anthelmintic therapy 5
Monitoring and Follow-up
- The Centers for Disease Control and Prevention states that serology may remain positive for many years after successful treatment and cannot be used to assess treatment success 1
Common Pitfalls to Avoid
- The World Health Organization warns that failing to adjust dosage based on Schistosoma species can lead to treatment failure 1
- The Infectious Diseases Society of America advises against using serology alone to assess treatment success, as antibodies persist for years 1
- The American Society of Tropical Medicine and Hygiene cautions that administering praziquantel during acute Katayama syndrome without steroids may worsen symptoms 4
- The Centers for Disease Control and Prevention recommends considering potential co-infection with strongyloidiasis before starting corticosteroids, which could precipitate hyperinfection syndrome 3
Treatment of Acute Schistosomiasis
Special Clinical Scenarios
- The World Health Organization recommends that for acute schistosomiasis (Katayama syndrome), treatment should include Praziquantel 40 mg/kg as a single dose at the time of diagnosis, with a repeat dose after 6-8 weeks, as eggs and immature schistosomules are relatively resistant to initial treatment, and a short course of oral prednisolone 20 mg/day for 5 days to reduce symptom duration 6
- In cases of acute schistosomiasis, repeating treatment after 6-8 weeks is necessary as immature forms may survive initial treatment 6
Treatment of Schistosomiasis with Praziquantel
Special Considerations
- For patients with specific conditions, such as pregnancy and lactation, or immunocompromised patients, refer to specialized guidelines for dosing adjustments and seek specialist advice for management, as recommended by the Journal of Infection 7
- The World Health Organization recommends a 40 mg/kg single-dose regimen for most Schistosoma species, but dosage adjustments may be necessary for certain species or patient populations, with guidance available from the Journal of Infection 7
Praziquantel Treatment for Schistosomiasis
Standard Treatment Duration
- The World Health Organization recommends a single treatment day with mandatory follow-up dosing, where Praziquantel is administered as a complete treatment on a single day, with a repeat dose 6-8 weeks after the initial dose, as immature schistosomules are relatively resistant to praziquantel 8
- In cases of documented treatment failure, the standard approach is to seek specialist advice rather than continuing standard dosing, and consider combination therapy with artemisinin derivatives, though clinical trial evidence is limited 8
Species-Specific Dosing Schedules
- For S. mansoni, S. haematobium, S. intercalatum, and S. guineensis, a single dose of 40 mg/kg on day 1, then repeat at 6-8 weeks is recommended 8
- For S. japonicum and S. mekongi, 60 mg/kg divided into two doses on the same day, then repeat at 6-8 weeks is recommended 8
Treatment Failure
- The Centers for Disease Control and Prevention suggests that if viable eggs persist after completing both doses, consider true treatment failure, and seek specialist advice rather than continuing standard dosing 8
Management of Coinfections and Contraindicated Therapies in Hepatic Schistosomiasis
Screening for Endemic Coinfections
Routine screening for endemic coinfections such as Salmonella species, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus should be performed before initiating antiparasitic therapy, because these infections can modify disease severity and influence treatment decisions. 9
In patients with schistosome‑associated glomerulonephritis who also have viral coinfections (HBV, HCV, or HIV), a kidney biopsy should be considered to guide management. 9
Contraindicated Use of Immunosuppressive Agents
- Immunosuppressive medications should never be used in schistosomal hepatopathy, as they provide no therapeutic benefit and may worsen clinical outcomes. 9